Holen Sie sich die Stockscreener-App
8.19
8.08%
-0.72
Handel nachbörslich:
8.19
Finanzdaten der Candel Therapeutics Inc-Aktie (CADL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
64.25%
26.75
|
16.28 | 15.75 | 13.21 | 11.18 |
| Interest Income/Expense |
0.70%
1.575
|
1.564 | 1.416 | 0.161 | 0.236 |
| Operating Income/Loss |
64.25%
-26.75
|
-16.28 | -15.75 | -13.21 | -11.18 |
| Nonoperating Income/Loss |
263.80%
-12.16
|
7.423 | -13.74 | 1.938 | 6.381 |
| Net Income/Loss |
339.06%
-38.91
|
-8.861 | -29.50 | -11.27 | -4.796 |
| Basic Average Shares |
18.87%
74.13
|
62.36 | - | 54.89 | 51.49 |
| Diluted Average Shares |
18.87%
74.13
|
62.36 | - | 54.89 | 51.49 |
| Basic Earnings Per Share |
271.43%
-0.52
|
-0.14 | - | -0.21 | -0.09 |
| Diluted Earnings Per Share |
271.43%
-0.52
|
-0.14 | - | -0.21 | -0.09 |
3.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):